Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4720)
All Articles published online
|
Apr 28, 2011 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Guan YS, Liu Y, He Q, Li X, Yang L, Hu Y, La Z. |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i16/2143.htm |
| Number | Citing Articles |
| 1 |
Hideaki Shimada. p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma. Annals of Gastroenterological Surgery 2018; 2(4): 266 doi: 10.1002/ags3.12179
|
| 2 |
Xinguo Li, Xiaonan Sun, Bingyuan Wang, Yiling Li, Jing Tong. Oncolytic virus-based hepatocellular carcinoma treatment: Current status, intravenous delivery strategies, and emerging combination therapeutic solutions. Asian Journal of Pharmaceutical Sciences 2023; 18(1): 100771 doi: 10.1016/j.ajps.2022.100771
|
| 3 |
Xing Gao, En Ren, Chengchao Chu, Yun Zeng, Gang Liu. Advances in Smart Nanomaterials and their Applications. 2023; : 51 doi: 10.1016/B978-0-323-99546-7.00019-7
|
| 4 |
Yu Xia, Xiuqin Li, Wei Sun. Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China. Current Gene Therapy 2020; 20(2): 127 doi: 10.2174/1566523220999200731003206
|
| 5 |
Dan Shao, Jing Li, Xuanang Xiao, Ming Zhang, Yue Pan, Shuo Li, Zheng Wang, Xin Zhang, Huilin Zheng, Xuewen Zhang, Li Chen. Real-Time Visualizing and Tracing of HSV-TK/GCV Suicide Gene Therapy by Near-Infrared Fluorescent Quantum Dots. ACS Applied Materials & Interfaces 2014; 6(14): 11082 doi: 10.1021/am503998x
|
| 6 |
Yi Li, Wei Guo, Xiuqin Li, Jianguo Zhang, Moyi Sun, Zhangui Tang, Wei Ran, Kai Yang, Guilin Huang, Longjiang Li. Expert consensus on the clinical application of recombinant adenovirus human p53 for head and neck cancers. International Journal of Oral Science 2021; 13(1) doi: 10.1038/s41368-021-00145-1
|
| 7 |
Shoupeng Sheng, Jiasheng Zheng, Shichang Cui, Xiongwei Cui, Zhiling Qian. Complete remission of multiple lung metastases after ablation of hepatocellular carcinoma by transarterial infusion with the p53 gene. Anti-Cancer Drugs 2015; 26(2): 227 doi: 10.1097/CAD.0000000000000167
|
| 8 |
Bo Li, Ning Gao, Zhuang Zhang, Qian‐Ming Chen, Long‐Jiang Li, Yi Li. Historical and Clinical Experiences of Gene Therapy for Solid Cancers in China. Genes 2017; 8(3): 85 doi: 10.3390/genes8030085
|
| 9 |
Abduh Murshed, Mohammed A. H. Alnoud, Saleem Ahmad, Safir Ullah Khan, Mohammed Alissa, Meshari A. Alsuwat, Ahmed Ezzat Ahmed, Munir Ullah Khan. Genetic Alchemy unveiled: MicroRNA-mediated gene therapy as the Artisan craft in the battlefront against hepatocellular carcinoma—a comprehensive chronicle of strategies and innovations. Frontiers in Genetics 2024; 15 doi: 10.3389/fgene.2024.1356972
|
| 10 |
Dongjie Liu, Mingyang Liu, Wenjing Wang, Lijun Pang, Zhenchang Wang, Chunwang Yuan, Kai Liu. Overexpression of apoptosis-inducing factor mitochondrion-associated 1 (AIFM1) induces apoptosis by promoting the transcription of caspase3 and DRAM in hepatoma cells. Biochemical and Biophysical Research Communications 2018; 498(3): 453 doi: 10.1016/j.bbrc.2018.02.203
|
| 11 |
Chao-Bin He, Xiao-Jun Lin, Sheng-Nan Lu. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101. PLOS ONE 2017; 12(3): e0174769 doi: 10.1371/journal.pone.0174769
|
| 12 |
David J Stewart, Maria I Nunez, Jaroslav Jelinek, David Hong, Sanjay Gupta, Marcelo Aldaz, Jean-Pierre Issa, Razelle Kurzrock, Ignacio I Wistuba. Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samples. Clinical Epigenetics 2014; 6(1) doi: 10.1186/1868-7083-6-13
|
| 13 |
Yong-Hua Xu, Shuo-Hui Liu, Fu-Rong Hao, Yin-Huan Zhang. Recombinant adenovirus p53 combined with radiotherapy improves efficacy and safety in the treatment of head and neck lymphoma. Cancer Biomarkers 2018; 23(2): 213 doi: 10.3233/CBM-181286
|
| 14 |
Hui Cao, Xiaosong Chen, Zhijun Wang, Lei Wang, Qiang Xia, Wei Zhang. The role of MDM2–p53 axis dysfunction in the hepatocellular carcinoma transformation. Cell Death Discovery 2020; 6(1) doi: 10.1038/s41420-020-0287-y
|
| 15 |
Julia Reetz, Ottmar Herchenröder, Anke Schmidt, Brigitte M. Pützer. Regenerative Medicine. 2013; : 475 doi: 10.1007/978-94-007-5690-8_19
|
| 16 |
Li Qi, Guiqing Li, Peipei Li, Hongwei Wang, Xiaolong Fang, Tongchuan He, Jingjing Li. Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology. Genes & Diseases 2024; 11(4): 101155 doi: 10.1016/j.gendis.2023.101155
|
| 17 |
Ai Shen, Shihong Liu, Weiqian Yu, Hejun Deng, Qingdong Li. p53 gene therapy‐based transarterial chemoembolization for unresectable hepatocellular carcinoma: A prospective cohort study. Journal of Gastroenterology and Hepatology 2015; 30(11): 1651 doi: 10.1111/jgh.13009
|
| 18 |
Shuhuan Liu, Yubo Guo, Rongqin Huang, Jianfeng Li, Shixian Huang, Yuyang Kuang, Liang Han, Chen Jiang. Gene and doxorubicin co-delivery system for targeting therapy of glioma. Biomaterials 2012; 33(19): 4907 doi: 10.1016/j.biomaterials.2012.03.031
|
| 19 |
Qiong Lin, Deng-Gao Wang, Zhu-Qin Zhang, De-Pei Liu. Applications of Virus Vector–Mediated Gene Therapy in China. Human Gene Therapy 2018; 29(2): 98 doi: 10.1089/hum.2017.238
|
| 20 |
Alireza Shahryari, Zahra Nazari, Marie Saghaeian Jazi, Fatemeh Hashemi-Shahraki, Katharina Wißmiller, Weiwei Xu, Ingo Burtscher, Heiko Lickert. Comprehensive Pharmacology. 2022; : 326 doi: 10.1016/B978-0-12-820472-6.00213-9
|
| 21 |
Yunpeng Sun, Huanhuan Wu, Gang Chen, Xiaming Huang, Yunfeng Shan, Hongqi Shi, Qiyu Zhang, Yihu Zheng. Genetically engineered recombinant adenovirus expressing interleukin‑2 for hepatocellular carcinoma therapy. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.7922
|
| 22 |
Sónia Duarte, Georges Carle, Henrique Faneca, Maria C. Pedroso de Lima, Valérie Pierrefite-Carle. Suicide gene therapy in cancer: Where do we stand now?. Cancer Letters 2012; 324(2): 160 doi: 10.1016/j.canlet.2012.05.023
|
| 23 |
Ender Gunes Yegin, Erkan Oymaci, Emrah Karatay, Ahmet Coker. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment. Hepatobiliary & Pancreatic Diseases International 2016; 15(3): 234 doi: 10.1016/S1499-3872(16)60097-8
|
| 24 |
Katherine E Redd Bowman, Phong Lu, Erica R Vander Mause, Carol S Lim. Advances in Delivery Vectors for Gene Therapy in Liver Cancer. Therapeutic Delivery 2020; 11(1): 833 doi: 10.4155/tde-2019-0076
|
| 25 |
Yi Li, Bo Li, Chun-Jie Li, Long-Jiang Li. Key points of basic theories and clinical practice in rAd-p53 (Gendicine™) gene therapy for solid malignant tumors. Expert Opinion on Biological Therapy 2015; 15(3): 437 doi: 10.1517/14712598.2015.990882
|
| 26 |
Junhe Zhang, Yunxi Xiao, Jie Zhang, Yun Yang, Liao Zhang, Fan Liang. Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-023-04817-w
|
| 27 |
Bryan Mckiver, Mohamad Imad Damaj, Devanand Sarkar. Assessment of Current Gene Therapy Practices in Hepatocellular Carcinoma. Gastrointestinal Disorders 2020; 2(4): 469 doi: 10.3390/gidisord2040042
|
| 28 |
Chao-Bin He, Xiang-Ming Lao, Xiao-Jun Lin. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study. Chinese Journal of Cancer 2017; 36(1) doi: 10.1186/s40880-017-0227-2
|
| 29 |
Robert E. Sobol, Yong-Song Guan, Long-Jiang Li, Wei-Wei Zhang, Zhaohui Peng, Kerstin B. Menander, Sunil Chada, Daniel C. Maneval, Jane A. Horowitz, Robert Warren, Gary L. Clayman, Stephen G. Swisher, W. Jarrard Goodman, John Nemunaitis, Jack A. Roth. p53 in the Clinics. 2013; : 189 doi: 10.1007/978-1-4614-3676-8_11
|
| 30 |
Wei-Wei Zhang, Longjiang Li, Dinggang Li, Jiliang Liu, Xiuqin Li, Wei Li, Xiaolong Xu, Michael J. Zhang, Lois A. Chandler, Hong Lin, Aiguo Hu, Wei Xu, Dominic Man-Kit Lam. The First Approved Gene Therapy Product for Cancer Ad-p53(Gendicine): 12 Years in the Clinic. Human Gene Therapy 2018; 29(2): 160 doi: 10.1089/hum.2017.218
|
| 31 |
Yixin Xie, Min Wang, Zhihui Dong, Huan Song, Lianping Li, Min Yang, Pengling Li, Jingjing Tian, Kan Zhang, Xiaomeng Xia, Tingting Zhang, Aiguo Tang. In vitro effects of Staphylococcus aureus enterotoxin C3 on T cell activation, proliferation and cytokine production. Molecular Medicine Reports 2017; 16(4): 4744 doi: 10.3892/mmr.2017.7199
|
| 32 |
Cho Naing, Han Ni, Htar Htar Aung, Norah Htet Htet, Dimitrinka Nikolova. Gene therapy for people with hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2024; 2024(7) doi: 10.1002/14651858.CD013731.pub2
|
| 33 |
Wei Cao, Ju-liang Zhang, Da-yun Feng, Xue-wu Liu, Yan Li, Li-feng Wang, Li-bo Yao, Hongxin Zhang, Jian Zhang. The effect of adenovirus-conjugated NDRG2 on p53-mediated apoptosis of hepatocarcinoma cells through attenuation of nucleotide excision repair capacity. Biomaterials 2014; 35(3): 993 doi: 10.1016/j.biomaterials.2013.09.096
|
| 34 |
Min Yang, Min Wang, Xianping Li, Yixin Xie, Xiaomeng Xia, Jingjing Tian, Kan Zhang, Fang Chen, Huan Song, Zhihui Dong, Aiguo Tang. Inhibition of constructed SEC3-ES lentiviral vector to proliferation, migration of Hela cells. Pathology - Research and Practice 2019; 215(2): 315 doi: 10.1016/j.prp.2018.10.017
|
| 35 |
Saad Saffo, Tamar H. Taddei. Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies. Digestive Diseases and Sciences 2019; 64(4): 1016 doi: 10.1007/s10620-019-05582-x
|
| 36 |
Charles Li, Linda Li, Andrew C. Keates. Targeting Cancer Gene Therapy with Magnetic Nanoparticles. Oncotarget 2012; 3(4): 365 doi: 10.18632/oncotarget.490
|
| 37 |
Ling-yan Jiang, Meng Lian, Hong Wang, Ju-gao Fang, Qi Wang. Inhibitory effects of 5-Aza-2′-deoxycytidine and trichostatin A in combination with p53-expressing adenovirus on human laryngocarcinoma cells. Chinese Journal of Cancer Research 2012; 24(3): 232 doi: 10.1007/s11670-012-0232-6
|